You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

550 Results
Drug
Other Name(s): Mekinist®
Jun 2025
Drug
Other Name(s): Trisenox®
Oct 2025
Drug
Other Name(s): Pomalyst®
Apr 2025
Drug
Other Name(s): Imbruvica®
Jan 2026
Drug
Other Name(s): Blincyto®
Nov 2025
Drug
Other Name(s): Sylvant®
Mar 2025
Drug
Other Name(s): Ibrance™
Oct 2025
Drug
Other Name(s): Ninlaro™
Jun 2019
Drug
Other Name(s): Venclexta®
Aug 2025
Drug
Other Name(s): Rydapt®
Jun 2025
Regimen
Intent: Palliative, Curative
Funding:
New Drug Funding Program
    Aldesleukin (interleukin-2) - In-Transit Metastases from Melanoma
May 2019
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Intent: Palliative
Nov 2019

Pages